Cargando…
Letter in response to the article: Pros and cons for use of statins in 59 people with coronavirus disease-19 (COVID-19)(Ray, S et al.)
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Diabetes India. Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687361/ https://www.ncbi.nlm.nih.gov/pubmed/33279832 http://dx.doi.org/10.1016/j.dsx.2020.11.017 |
| _version_ | 1783613500373860352 |
|---|---|
| author | Zhao, Tie Peng, Liang |
| author_facet | Zhao, Tie Peng, Liang |
| author_sort | Zhao, Tie |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7687361 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Diabetes India. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76873612020-11-25 Letter in response to the article: Pros and cons for use of statins in 59 people with coronavirus disease-19 (COVID-19)(Ray, S et al.) Zhao, Tie Peng, Liang Diabetes Metab Syndr Letter to the Editor Diabetes India. Published by Elsevier Ltd. 2021 2020-11-25 /pmc/articles/PMC7687361/ /pubmed/33279832 http://dx.doi.org/10.1016/j.dsx.2020.11.017 Text en © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Zhao, Tie Peng, Liang Letter in response to the article: Pros and cons for use of statins in 59 people with coronavirus disease-19 (COVID-19)(Ray, S et al.) |
| title | Letter in response to the article: Pros and cons for use of statins in 59 people with coronavirus disease-19 (COVID-19)(Ray, S et al.) |
| title_full | Letter in response to the article: Pros and cons for use of statins in 59 people with coronavirus disease-19 (COVID-19)(Ray, S et al.) |
| title_fullStr | Letter in response to the article: Pros and cons for use of statins in 59 people with coronavirus disease-19 (COVID-19)(Ray, S et al.) |
| title_full_unstemmed | Letter in response to the article: Pros and cons for use of statins in 59 people with coronavirus disease-19 (COVID-19)(Ray, S et al.) |
| title_short | Letter in response to the article: Pros and cons for use of statins in 59 people with coronavirus disease-19 (COVID-19)(Ray, S et al.) |
| title_sort | letter in response to the article: pros and cons for use of statins in 59 people with coronavirus disease-19 (covid-19)(ray, s et al.) |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687361/ https://www.ncbi.nlm.nih.gov/pubmed/33279832 http://dx.doi.org/10.1016/j.dsx.2020.11.017 |
| work_keys_str_mv | AT zhaotie letterinresponsetothearticleprosandconsforuseofstatinsin59peoplewithcoronavirusdisease19covid19raysetal AT pengliang letterinresponsetothearticleprosandconsforuseofstatinsin59peoplewithcoronavirusdisease19covid19raysetal |